eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry and Food and Drug Administration Staff: Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications; Availability

Draft Guidance for Industry and Food and Drug Administration Staff: Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications; Availability

Document ID: FDA-2009-D-0490-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E9-25136
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NAD-Notice of Availability of Data
Received Date: October 19 2009, at 01:46 PM Eastern Daylight Time
Start-End Page: 53751 - 53752
Page Count: 2
Comment Start Date: October 20 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: January 19 2010, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 6
Dana-Farber Cancer Institute - Comment
Posted: 01/07/2010     ID: FDA-2009-D-0490-0004

Jan 19,2010 11:59 PM ET
Puget Sound Blood Center - Comment
Posted: 01/13/2010     ID: FDA-2009-D-0490-0005

Jan 19,2010 11:59 PM ET
St Louis Cord Blood Bank - Comment
Posted: 01/19/2010     ID: FDA-2009-D-0490-0008

Jan 19,2010 11:59 PM ET
StemCyte - Comment
Posted: 01/26/2010     ID: FDA-2009-D-0490-0009

Jan 19,2010 11:59 PM ET
Daniel Weisdorf - Comment
Posted: 01/06/2010     ID: FDA-2009-D-0490-0003

Jan 19,2010 11:59 PM ET

Related Documents

Total: 0
No documents available.